Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Journal of Fungi (Basel, Switzerland)|February 7, 2020
Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological MalignanciesMaroun M Sfeir, Cristina Jiménez-Ortigosa, Maria N Gamaletsou, et al.Science (New York, N.Y.)|December 4, 1981
Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swineD G Kleid, D Yansura, B Small, et al.Plos One|May 15, 2014
Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trialDavid A Wohl, Laveeza Bhatti, Catherine B Small, et al.Antiviral Therapy|December 8, 2016
Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trialJuergen K Rockstroh, Frank Plonski, Meena Bansal, et al.HIV Medicine|July 16, 2015
The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavirD A Wohl, L Bhatti, C B Small, et al.Neurology|December 10, 2008
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer diseaseR Duara, D A Loewenstein, E Potter, et al.American Journal of Veterinary Research|March 1, 1985
Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattleP D McKercher, D M Moore, D O Morgan, et al.HIV Clinical Trials|April 30, 2015
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agentsJuergen K Rockstroh, Vicente Soriano, Frank Plonski, et al.Journal of Virology|June 1, 1985
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12B H Robertson, M J Grubman, G N Weddell, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2019
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant RecipientsWesley S Rogers, Lars F Westblade, Rosemary Soave, et al.Pageof 13